Biden maps out a ‘moonshot’ approach to cancer with plans to ‘break down silos’ in R&D

Damian Garde Vice President Joe Biden fleshed out his plans to take the lead on a global effort to bolster cancer research, hoping to unite industry and academia to push new therapies ...

Pharma to EU officials: We need ‘contingency’ supply plans in case of ‘Grexit’

Tracy Staton Drugmakers are raising an alarm about shortages in Greece as the possibility of a "Grexit" looms. That "worst-case scenario" could put supplies in peril, ...

Biotie ups IPO as UCB exits, Targovax merges to forge Nordic I-O player, Cosmo plans IPO

Nick Paul Taylor In this week's EuroBiotech Report, Biotie Therapies, Cosmo Pharmaceuticals, Targovax and Pieris Pharmaceuticals are all advancing plans to raise cash from public ...

U.S. FDA plans to double drug inspectors in India as marketing applications soar

EJ Lane The U.S. FDA is hiring new inspectors in India to tackle the high rate of marketing applications made by local firms, an agency official said. FiercePharma News

Big shot investor plans £100M EU biotech fund, Genmab up on PhII data, J&J inks U.K. RA deal

Nick Paul Taylor In this week's EuroBiotech Report, after years of relying heavily on Neil Woodford's checkbook, early-stage British and European biotechs could soon have another ...

Little Cortendo gains $11M for late-stage Cushing’s study, hatches U.S. IPO plans

John Carroll Cortendo is coming to America. Founded in Sweden, the little biotech has a new CEO who's building the executive team in the Philadelphia area. And he's dropping ...

IPO hopeful rEVO puts off its plans for a $75M debut

Damian Garde Massachusetts biotech rEVO Biolgoics is postponing its efforts to go public in a $ 75 million IPO. FierceBiotech News

Don’t get too excited, investors: GSK has no near-term plans for consumer health spinoff

Carly Helfand Let GlaxoSmithKline be clear: It's open to spinning off its consumer healthcare division at some nebulous point in the future. But it's not happening anytime soon. FiercePharma ...

Puma shares triple on positive PhIII neratinib data, plans to file for approval

John Carroll FierceBiotech News

Merck R&D adopts its rivals’ game plans in global overhaul

John Carroll When Merck announced back at the beginning of October that it was triggering a massive shakeup of its R&D operations after a 7-year blockbuster drought, the pharma ...

Are Federal Call Centers Up To The Task Of Enrolling Millions In Health Plans?

barbara.lempert Are Federal Call Centers Up To The Task Of Enrolling Millions In Health Plans? By Phil Galewitz KHN Staff Writer HARTFORD, Conn., Oct 24, 2013 — An elderly man ...

Guardian Introduces Stop Loss Insurance for Self-Funded Health Plans

barbara.lempert Helps Limit Financial Risk for Employers from Unpredictable Claims October 10, 2013 10:08 AM Eastern Daylight Time NEW YORK–(BUSINESS WIRE)–The Guardian ...
© 2019 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS